Novel Glucose Metric "Latest Spike Time" Correlated with Weight Loss at Six Months in People with Obesity Using the Signos System.

IF 5.7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Diabetes technology & therapeutics Pub Date : 2024-08-19 DOI:10.1089/dia.2024.0222
William Dixon, Stephanie Kim, Dmitri Levonian, Dan Gusz, Sharam Fouladgar-Mercer, Jay S Skyler
{"title":"Novel Glucose Metric \"Latest Spike Time\" Correlated with Weight Loss at Six Months in People with Obesity Using the Signos System.","authors":"William Dixon, Stephanie Kim, Dmitri Levonian, Dan Gusz, Sharam Fouladgar-Mercer, Jay S Skyler","doi":"10.1089/dia.2024.0222","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Introduction:</i></b> The rise of digital health applications utilizing continuous glucose monitoring (CGM) allows for novel assessments of glucose management and weight changes in people without diabetes. The Signos System incorporates a digital health app paired with a CGM to provide information and prompts aimed to help people without diabetes to manage weight. <b><i>Objectives:</i></b> The primary objective of this study was to determine whether the average timing of the latest chronological glucose excursion (\"spike\") was correlated with amount of weight loss. <b><i>Methods:</i></b> This was a retrospective analysis of prospectively obtained glucose and weight data from people without diabetes who enrolled in the Signos System from November 2021 to August 2023. Participants were provided CGMs as well as encouraged to use the Signos app with personalized advice and logging capabilities for weight, food, physical activity, heart rate, sleep, and activities. \"Latest spike time\" (LST) was retrospectively derived from CGM data and compared with weight changes at 6 months. <b><i>Results:</i></b> Nine hundred and twenty-six subjects met the inclusion criteria including sufficient days wearing a CGM and a weight log within 15 days of 6 months from their first weight log. There was a strong correlation between an earlier spike time and increased weight loss. The top quintile of subjects, with an average LST before 5:41 PM, lost over three times as much weight as the bottom quintile of users, with LST after 8:40 PM; this separation was predictable within 1 month of data. <b><i>Conclusion:</i></b> In a large population of obese people without diabetes, continuous glucose data, specifically a novel metric \"LST,\" was highly correlated with percentage of total body weight loss at 6 months. This research suggests that for people attempting weight loss, review and alteration of behaviors relating to later glucose excursions may be of specific benefit.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/dia.2024.0222","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The rise of digital health applications utilizing continuous glucose monitoring (CGM) allows for novel assessments of glucose management and weight changes in people without diabetes. The Signos System incorporates a digital health app paired with a CGM to provide information and prompts aimed to help people without diabetes to manage weight. Objectives: The primary objective of this study was to determine whether the average timing of the latest chronological glucose excursion ("spike") was correlated with amount of weight loss. Methods: This was a retrospective analysis of prospectively obtained glucose and weight data from people without diabetes who enrolled in the Signos System from November 2021 to August 2023. Participants were provided CGMs as well as encouraged to use the Signos app with personalized advice and logging capabilities for weight, food, physical activity, heart rate, sleep, and activities. "Latest spike time" (LST) was retrospectively derived from CGM data and compared with weight changes at 6 months. Results: Nine hundred and twenty-six subjects met the inclusion criteria including sufficient days wearing a CGM and a weight log within 15 days of 6 months from their first weight log. There was a strong correlation between an earlier spike time and increased weight loss. The top quintile of subjects, with an average LST before 5:41 PM, lost over three times as much weight as the bottom quintile of users, with LST after 8:40 PM; this separation was predictable within 1 month of data. Conclusion: In a large population of obese people without diabetes, continuous glucose data, specifically a novel metric "LST," was highly correlated with percentage of total body weight loss at 6 months. This research suggests that for people attempting weight loss, review and alteration of behaviors relating to later glucose excursions may be of specific benefit.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新的血糖指标 "最新峰值时间 "与使用 Signos 系统的肥胖症患者 6 个月后的体重减轻相关。
简介利用连续血糖监测仪(CGM)的数字健康应用程序的兴起,可以对非糖尿病患者的血糖管理和体重变化进行新颖的评估。Signos 系统将数字健康应用程序与连续血糖监测仪结合在一起,提供信息和提示,旨在帮助非糖尿病患者控制体重:本研究的主要目的是确定最近一次血糖偏高("峰值")的平均时间是否与体重减轻量相关:这是对 2021 年 11 月至 2023 年 8 月期间加入 Signos 系统的非糖尿病患者前瞻性获得的血糖和体重数据进行的回顾性分析。向参与者提供 CGM,并鼓励他们使用 Signos 应用程序,该应用程序具有个性化建议和体重、食物、体力活动、心率、睡眠和活动记录功能。从 CGM 数据中追溯得出 "最新峰值时间",并与六个月时的体重变化进行比较:结果:926 名受试者符合纳入标准,其中包括佩戴 CGM 的足够天数,以及自首次体重记录起 6 个月内 15 天内的体重记录。峰值时间越早,体重减轻越多,两者之间存在很强的相关性。前五分之一受试者的平均最晚尖峰时间在下午 5:41 之前,其体重减轻是后五分之一用户(最晚尖峰时间在下午 8:40 之后)的三倍多;这种差异在一个月的数据中是可以预测的:结论:在大量无糖尿病的肥胖人群中,连续血糖数据,特别是新指标 "最新峰值时间",与六个月后体重减轻的百分比高度相关。这项研究表明,对于试图减肥的人来说,回顾和改变与后期血糖偏移有关的行为可能会有特别的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Diabetes technology & therapeutics
Diabetes technology & therapeutics 医学-内分泌学与代谢
CiteScore
10.60
自引率
14.80%
发文量
145
审稿时长
3-8 weeks
期刊介绍: Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
期刊最新文献
A Telehealth Program Using Continuous Glucose Monitoring and a Connected Insulin Pen Cap in Nursing Homes for Older Adults with Insulin-Treated Diabetes: The Trescasas Study. Comment on Preechasuk et al: Switching from Intermittently-Scanned Continuous Glucose Monitoring to Real-Time Continuous Glucose Monitoring with a Predictive Urgent Low Soon Alert Reduces Exposure to Hypoglycemia. The Impact of Public Policy on Equitable Access to Technology for Children and Youth Living with Type 1 Diabetes in British Columbia, Canada. Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control. Impact of Continuous Glucose Monitoring Versus Blood Glucose Monitoring to Support a Carbohydrate-Restricted Nutrition Intervention in People with Type 2 Diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1